Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy.
Krzystolik
Magdalena G
MG
Southern New England Retina Associates, Providence, RI 02904, USA. magdalena_krzystolik@brown.edu
Filippopoulos
Theodoros
T
Ducharme
Joseph F
JF
Loewenstein
John I
JI
D052157:Aptamers, Nucleotide / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003930:Diabetic Retinopathy / Q000150:complications*; D020327:Glaucoma Drainage Implants; D015355:Glaucoma, Neovascular / Q000209:etiology / Q000503:physiopathology / Q000601:surgery; D006068:Gonioscopy; D006801:Humans; D007267:Injections; D007498:Iris / Q000098:blood supply*; D019654:Lens Implantation, Intraocular; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D018918:Phacoemulsification; D011183:Postoperative Complications; D014821:Vitrectomy
D052157:Aptamers, Nucleotide; C495058:pegaptanib